Remicade (infliximab) is a prescription drug that’s used to treat certain autoimmune conditions. This drug can interact with certain vaccines and other medications, such as immunosuppressant ...

Johnson & Johnson has come out fighting after Pfizer announced yesterday that it is ready to launch a biosimilar competitor to its blockbuster Remicade. J&J said it had a “biosimilar ...